Ocumension Therapeutics (FRA:5DG)
Germany · Delayed Price · Currency is EUR 0.8750
+0.0250 (2.94%)
Last updated: Nov 27, 2025, 10:30 AM CET
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of €729.47 million as of December 2, 2025. Its market cap has increased by 36.29% in one year.
Market Cap
729.47M
Enterprise Value
669.55M
Revenue
64.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.88
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 2.43B to 729.47M, a decrease of -69.95%. That is a compound annual growth rate of -19.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 729.47M | 59.82% |
| Dec 31, 2024 | 456.43M | -14.58% |
| Dec 29, 2023 | 534.31M | -32.64% |
| Dec 30, 2022 | 793.26M | -39.71% |
| Dec 31, 2021 | 1.32B | -21.82% |
| Dec 31, 2020 | 1.68B | -30.67% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |